ICLR ICON Public Limited Company
ICLR ICON Public Limited Company
Healthcare · Diagnostics & Research
Desk view
Market read
POC $166.71 · VWAP $139.34 · +22.1% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, CFO + 7 others sold $1.7M, Aug 11–12
Coverage
2 watchlists
ICLR Price Structure
Loading timeframes…
Peers
Every watchlist ICLR belongs to, members best 30-day change first — ICLR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
@ibb
Reported the quarter ending 2026-06-30: revenue $2.06B, diluted EPS $0.94, net income $73M (SEC filing). Across the print the stock moved -8.2% (close before → first close after).
full note →Against street estimates
How ICLR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about ICLR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 16 days ago · Oct 1
- ICON plc: ICLR Stock Price Quote & News | Robinhood
- ICON (Nasdaq:ICLR) - Stock Analysis - Simply Wall St
- ICON plc (ICLR) rises as investors appear to lean on backlog, guidance, and recent filings | Quiver Quantitative
- ICON Public Limited Company (ICLR) Stock Price, News, Quote & History - Yahoo Finance
- ICLR Stock Quote Price and Forecast | CNN
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
ICLR research tape
2 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.